Prasad Apsangikar

Randomised, Double-blind, Comparative Clinical Study of New Ranibizumab Biosimilar in Neovascular (Wet) Age-Related Macular Degeneration

Prasad Apsangikar, Pravin Ghadge, Manoj Naik et al. · Clinical ophthalmology · 2021 · 21 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

Comparative pharmacokinetics, efficacy, and safety of bevacizumab biosimilar to reference bevacizumab in patients with metastatic colorectal cancer

Prasad Apsangikar, Sunil Chaudhry, Shashank Deoghare et al. · Indian Journal of Cancer · 2017 · 14 citations

Medicine, Oncology, Pharmacokinetics +12

A comparative phase III clinical study to evaluate efficacy and safety of TrastuRel™ (biosimilar trastuzumab) and innovator trastuzumab in patients with metastatic human epidermal growth factor receptor 2 (HER2)-overexpressing breast cancer

Prasad Apsangikar, Sunil Chaudhry, Manoj Naik et al. · Indian Journal of Cancer · 2017 · 10 citations

Medicine, Oncology, Pharmacology +16

Randomized Comparative Clinical Study of First Global Omalizumab Biosimilar with Innovator Product in Moderate to Severe Persistent Asthma.

Prasad Apsangikar, Pravin Ghadge, Manoj Naik et al. · PubMed · 2020 · 10 citations

Pharmacy, Pharmacology, Pharmacotherapy +17